Publication | Open Access
Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity
14
Citations
20
References
2020
Year
Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityAntitumor ImmunityCellular Immune ResponseIl-2r SignalingImmunotherapyLimited DurationCell Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1